GATA2, a transcription factor essential for hematopoiesis and immune function, has been associated with a range of clinical manifestations, including immunodeficiency, myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML) [60,61]. This evidence concerns the gene GATA2 and myelodysplastic syndrome.